We present studies of the delivery of short interfering ribonucleic acid (siRNA) into a green fluorescent protein (GFP) expressing cell line, using lipid nanocarriers in cubic lyotropic liquid crystal form. These carriers are based on glycerol monooleate (GMO) and employ the use of varying concentrations of cationic siRNA binding lipids. The essential physicochemical parameters of the cationic lipid/GMO/siRNA complexes such as particle size, ζ otential, siRNA uptake stability, lyotropic mesophase behavior, cytotoxicity,and gene silencing efficiency were systematically assessed. We find that the lipid nanocarriers were effectively taken up by mammalian cells and that their siRNA payload was able to induce gene silencing in vitro. More import...
The discovery of potent new materials for in vivo delivery of nucleic acids depends upon successful ...
Small interfering RNAs (siRNAs) indicate the unprecedented versatility in silencing disease-causing ...
ABSTRACT: Small interfering RNAs (siRNAs) of 19-25 bp mediate the cleavage of complementary mRNA, le...
Despite the use of small interfering RNAs (siRNAs) as therapeutic agents through the knockdown expre...
International audienceRNA interference discovery has opened up new fields of study, including the un...
Safe and efficient delivery of small interfering RNA (siRNA) is essential to gene therapy towards in...
The use of small interfering RNAs (siRNAs) to silence specific genes is::one of the most promising a...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
RNA interference (RNAi) technology has shown great promise for the treatment of cancer and other gen...
The insertion of biocompatible amino acid moieties in non-viral gene nanocarriers is an attractive a...
Synthetic short interfering RNA (siRNA) oligonucleotides can trigger the RNA interference pathway an...
The clinical success of therapeutics of small interfering RNA (siRNA) is still hindered by its deliv...
Macromolecules such as nucleic acids and inorganic nanoparticles require a delivery vector to capit...
Objective(s): Lipid-based nanoparticles (NLP) are PEGylated carriers composed of lipids and encapsul...
The discovery of potent new materials for in vivo delivery of nucleic acids depends upon successful ...
Small interfering RNAs (siRNAs) indicate the unprecedented versatility in silencing disease-causing ...
ABSTRACT: Small interfering RNAs (siRNAs) of 19-25 bp mediate the cleavage of complementary mRNA, le...
Despite the use of small interfering RNAs (siRNAs) as therapeutic agents through the knockdown expre...
International audienceRNA interference discovery has opened up new fields of study, including the un...
Safe and efficient delivery of small interfering RNA (siRNA) is essential to gene therapy towards in...
The use of small interfering RNAs (siRNAs) to silence specific genes is::one of the most promising a...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
Cationic lipid- and polymer-based nanodevices are considered appropriate alternatives for virus-base...
RNA interference (RNAi) technology has shown great promise for the treatment of cancer and other gen...
The insertion of biocompatible amino acid moieties in non-viral gene nanocarriers is an attractive a...
Synthetic short interfering RNA (siRNA) oligonucleotides can trigger the RNA interference pathway an...
The clinical success of therapeutics of small interfering RNA (siRNA) is still hindered by its deliv...
Macromolecules such as nucleic acids and inorganic nanoparticles require a delivery vector to capit...
Objective(s): Lipid-based nanoparticles (NLP) are PEGylated carriers composed of lipids and encapsul...
The discovery of potent new materials for in vivo delivery of nucleic acids depends upon successful ...
Small interfering RNAs (siRNAs) indicate the unprecedented versatility in silencing disease-causing ...
ABSTRACT: Small interfering RNAs (siRNAs) of 19-25 bp mediate the cleavage of complementary mRNA, le...